This Patient Is Most Likely To Have Plaque Psoriasis The Mos

This Patient Is Most Likely To Have Plaque Psoriasis The Most Common Esteemed colleagues and healthcare professionals, the diagnosis of psoriasis, particularly the plaque type, hinges upon a thorough understanding of epidemiology, clinical features, predisposing factors, and differential diagnoses. The patient under consideration most likely presents with plaque psoriasis, the most prevalent form of psoriasis in young adults, characterized by well-defined, erythematous plaques with silvery scales. The mean age of onset is typically in the early twenties, aligning with epidemiological data as presented by Dunphy et al. (2015). Recognizing the significance of familial history is instrumental, as approximately one-third of psoriasis patients have a first-degree relative with the disease. The risk escalates when both parents are affected, with studies indicating a 41% chance of offspring developing psoriasis, underscoring a potent genetic component. Environmental triggers, such as recent upper respiratory infections observed in this patient, can precipitate or exacerbate psoriatic outbreaks. Although the precise genetic underpinnings remain elusive, research continues to explore how genetic predispositions interact with environmental factors to influence disease expression. Diagnostic evaluation should encompass laboratory tests including a complete blood count with differential, serum chemistry profile, serum uric acid levels, antinuclear antibody (ANA) titers, and rheumatoid factor to rule out differential diagnoses and evaluate systemic involvement. Elevated serum uric acid may be associated with psoriatic pathology, particularly in cases with psoriatic arthritis. Additionally, clinical assessment tools such as the Psoriasis Area and Severity Index (PASI) and the Dermatology Life Quality Index (DLQI) are crucial for determining disease severity and its impact on the patient’s quality of life. Differential diagnoses should be carefully considered; the top three differentials include seborrheic dermatitis, nummular eczema, and atopic dermatitis, which share overlapping clinical features but can be distinguished based on their distribution, lesion morphology, and accompanying symptoms (Dominic, Bolder, & Golding, 2019). Management of plaque psoriasis emphasizes the importance of identifying and avoiding triggers that precipitate flares. For mild to moderate disease, topical therapies such as emollients—particularly petrolatum—are foundational in maintaining skin hydration and reducing scaling. Topical corticosteroids remain the mainstay of initial therapy, offered in varying potencies to balance efficacy and minimize adverse effects like skin atrophy. It is recommended to limit corticosteroid use to no longer than four weeks to prevent local and systemic side effects (Hendriks et al., 2013).